Australia markets open in 5 hours 25 minutes

CVS Health Corporation (CVSD.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
56.780.00 (0.00%)
At close: 04:25PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) 71.07B
Enterprise value 135.23B
Trailing P/E 10.67
Forward P/E 8.65
PEG ratio (5-yr expected) 1.57
Price/sales (ttm)0.22
Price/book (mrq)1.03
Enterprise value/revenue 0.40
Enterprise value/EBITDA 8.44

Trading information

Stock price history

Beta (5Y monthly) 0.52
52-week change 3-9.70%
S&P500 52-week change 324.60%
52-week high 368.12
52-week low 356.78
50-day moving average 364.26
200-day moving average 365.83

Share statistics

Avg vol (3-month) 31
Avg vol (10-day) 35
Shares outstanding 51.26B
Implied shares outstanding 61.28B
Float 81.25B
% held by insiders 10.12%
% held by institutions 182.21%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.49
Forward annual dividend yield 44.39%
Trailing annual dividend rate 32.48
Trailing annual dividend yield 34.37%
5-year average dividend yield 4N/A
Payout ratio 443.51%
Dividend date 3N/A
Ex-dividend date 419 Apr 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.04%
Operating margin (ttm)2.13%

Management effectiveness

Return on assets (ttm)3.18%
Return on equity (ttm)10.09%

Income statement

Revenue (ttm)359.66B
Revenue per share (ttm)281.15
Quarterly revenue growth (yoy)3.60%
Gross profit (ttm)N/A
EBITDA 16.92B
Net income avi to common (ttm)7.32B
Diluted EPS (ttm)5.32
Quarterly earnings growth (yoy)-47.90%

Balance sheet

Total cash (mrq)13.09B
Total cash per share (mrq)10.43
Total debt (mrq)81.79B
Total debt/equity (mrq)110.31%
Current ratio (mrq)0.81
Book value per share (mrq)59.08

Cash flow statement

Operating cash flow (ttm)10.89B
Levered free cash flow (ttm)8.36B